DPDP for the Marketing department in Healthcare

Research with identifiable patients needs informed consent under research rules and DPDP consent for that use. Clinical audit to improve care within the hospital usually fits the treatment purpose. Case studies and teaching material should be de-identified so patients cannot be recognised. Clinical trials follow the NDCT Rules, 2019.

Section 6 sets consent; Section 17(2)(b) covers research only where no decision is taken about the person and prescribed standards are followed. Section 6 · Section 7 · Section 8(5) · Rule 6

1. Route research through the ethics committee.
2. Take research consent separately.
3. De-identify teaching cases and photos.
4. Limit researcher access.
5. Delete or anonymise at the end.

• Ethics approvals
• Research consents
• De-identification checks

• Photos with faces or tattoos in slides
• Using records for studies without approval
• Keeping research data with names after the study

• Do we need DPDP consent to treat a patient?
• When do we need consent, and when can we rely on a legitimate use?
• How long can we keep personal data?

Usually not for the treatment itself. A patient who comes for care gives data voluntarily for that purpose, and a medical emergency involving a threat to life is a listed use. Clinical consent for procedures is a separate medical and legal requirement and stays. Extra uses such as research, marketing, testimonials and sharing beyond what care and billing need do require DPDP consent.

Section 7(a) covers data given voluntarily for a specified purpose; Section 7(f) and 7(g) cover emergencies and epidemics. Section 7 · Section 6 · Section 5 · Rule 3

1. Keep clinical consent forms as they are.
2. Add a short notice at registration.
3. Add separate boxes for research, offers and stories.
4. Record which box each patient ticked.
5. Train front desk to explain the difference.

• Registration notice
• Consent records for extra uses

• One form that bundles treatment and marketing
• Calling clinical consent 'DPDP consent'
• No notice at registration

• What should our privacy notice say, and where must people see it?
• Can we use patient data for research, audits or case studies?
• Can we share patient records with insurers and TPAs?

Marketing needs consent that is separate and specific, unless the person clearly expects it from the relationship. Bought or scraped lead lists are risky because you cannot show consent. Every message should carry an easy way to stop.

Health package offers to past patients need separate consent.

Section 6 sets the consent standard. Section 5 needs a notice. Section 9 bars targeted advertising at children. Section 6 · Section 5 · Rule 3 · Section 9 · Rules 10, 12

1. Separate service messages from marketing messages.
2. Ask marketing consent separately, with a clear action.
3. Stop using bought lists unless the seller can show consent for you.
4. Add an easy stop option to every message.
5. Respect the telecom preference rules for calls and SMS.

• Marketing consent records
• Lead source records
• Stop requests and their handling

• Treating account sign-up as marketing consent
• Agency lists with no consent proof
• A stop option that does not work

• When do we need consent, and when can we rely on a legitimate use?
• Someone withdraws consent. What has to stop, and how fast?
• Do we process children's data, and what changes if we do?

For every use of personal data you need one basis: consent, or one of the legitimate uses in Section 7, such as a legal duty, employment, a medical emergency, or data a person gave voluntarily for a specific purpose. Anything beyond what the person expects, such as marketing, profiling or sharing with partners, usually needs consent.

Treatment rests on the patient's purpose; research, offers and testimonials need consent.

Section 4 allows processing only with consent or for a legitimate use. Section 6 sets what valid consent looks like. Section 7 lists the uses that need no consent. Section 4 · Section 6 · Section 7

1. List each purpose for which you use personal data.
2. Against each purpose, write the basis: consent or the exact clause of Section 7.
3. Where the basis is consent, check that it was asked separately, with a clear action and no pre-ticked box.
4. Stop or re-paper any purpose with no basis.
5. Review the list whenever a new product, campaign or system starts.

• Purpose and basis register
• Consent records with date, version and channel
• Legal sign-off on each legitimate use relied on

• Treating account terms as consent for marketing
• Bundling several purposes in one tick-box
• Relying on 'legitimate interest', which the Indian Act does not have

• What should our privacy notice say, and where must people see it?
• Someone withdraws consent. What has to stop, and how fast?
• Can we send offers to past customers and leads?

Withdrawal must be as easy as giving consent. Once someone withdraws, you and every vendor working for you must stop that use within a reasonable time. What was done before withdrawal stays lawful, and data that a law requires you to keep is kept.

A patient who withdraws consent for offers keeps receiving care.

Section 6(4) to 6(6) give the right to withdraw at any time, with the same ease, and require processors to stop as well. Section 8(7) then asks for erasure unless a law requires retention. Section 6 · Section 8(7) · Rule 8 · Section 8(1)–(2)

1. Give one simple way to withdraw on every channel where consent is taken.
2. Record the withdrawal against the person and the purpose.
3. Push the change to every system and vendor that uses that purpose.
4. Confirm to the person, in writing, what has stopped and what is kept by law.
5. Check a sample every month to see that the change actually reached every list.

• Withdrawal log with time stamps
• Proof that downstream systems and vendors updated
• Confirmation sent to the person

• Withdrawal by email only, while consent was one tap in an app
• Stopping in the main system but not in vendor lists
• Deleting records a law requires you to keep

• When do we need consent, and when can we rely on a legitimate use?
• Someone asks us to delete their data. Must we?
• What must a vendor contract say about personal data?

A notice must tell people, in plain words, what data you collect, why, how they can withdraw consent, how they can use their rights and how they can complain to the Data Protection Board. It has to stand on its own, separate from long terms and conditions, and be shown at the point where data is collected.

Registration desks, appointment apps, lab forms and health-camp sign-ups need short notices in the languages patients speak.

Section 5 and Rule 3 ask for a notice that can be understood on its own, with an itemised list of the data and the purpose for each item. Data you already hold from before the Act also needs a notice, as soon as reasonably practicable. Section 5 · Rule 3 · Section 6 · Sections 11–14 · Rule 14

1. List every point where personal data comes in: forms, apps, counters, calls, emails, partner feeds.
2. Write one short notice per collection point, with the data items and purpose side by side.
3. Add how to withdraw consent, how to make a request and the DPO or contact person's details.
4. Offer the notice in English and in the languages your patients actually use.
5. Keep each version with the date it went live.

• Screenshots or copies of the notice at each collection point, with dates
• Notice version history
• Translations, where used

• Hiding the notice inside terms and conditions
• One notice for everything, with no link between data items and purposes
• Forgetting old data collected before the Act

• When do we need consent, and when can we rely on a legitimate use?
• Someone withdraws consent. What has to stop, and how fast?
• Someone asks what data we hold about them. What do we send?

Anyone under 18 is a child under the Act. For a child's data you need verifiable consent from a parent or lawful guardian, and you must not track, behaviourally monitor or show targeted ads to children. Some classes and purposes are exempt under Rule 12 and the Fourth Schedule, for example healthcare to the extent needed to protect the child's health, and educational institutions for their educational work.

Paediatric care is exempt from parent-consent limits only to the extent needed to protect the child's health; marketing to parents of children is not.

Section 9 sets the duties. Rule 10 explains how to verify the parent. Rule 12 and the Fourth Schedule list the exemptions. Section 9 · Rules 10, 12 · Section 6

1. Find where children's data enters: customers, dependants, interns, visitors, scholarships, app sign-ups.
2. Decide whether an exemption in the Fourth Schedule applies to that purpose.
3. Where none applies, add an age question and a parent-consent step.
4. Switch off tracking and targeted ads for under-18 users.
5. Record the decision for each channel.

• Channel-by-channel note on children's data
• Parent-consent records
• Ad and tracking settings

• Assuming 'we are B2B, so no children'
• Using the age 13 or 16 from foreign laws
• Treating a tick-box from the child as parental consent

• When do we need consent, and when can we rely on a legitimate use?
• What should our privacy notice say, and where must people see it?
• Can we send offers to past customers and leads?

You stay responsible for what your vendors do with personal data. The contract should say what data they get, for what purpose, the security they must keep, how fast they must tell you about an incident, that sub-contractors need your approval, and how data is returned or deleted at the end.

Labs, teleradiology, HIS vendors, TPAs and ambulance services.

Section 8(1) keeps responsibility with you. Section 8(2) allows a processor only under a valid contract. Rule 6 asks for security terms in that contract. Section 8(1)–(2) · Section 8(5) · Rule 6 · Section 8(6) · Rule 7 · Section 8(7) · Rule 8

1. List vendors who receive or can see personal data.
2. Rank them by how much and how sensitive.
3. Add a data-protection schedule to each contract, starting with the top ten.
4. Ask for evidence: certificates, test results, deletion confirmations.
5. Review the top vendors every year.

• Vendor register
• Signed data-protection schedules
• Annual review notes

• Relying on the vendor's standard terms
• No incident-notice time
• No exit and deletion clause

• Something has gone wrong. What happens in the first 72 hours?
• Can personal data be stored or accessed outside India?
• Does deletion have to reach backups and test copies?